{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:13:06Z","timestamp":1794917586000,"version":"4.9.1"},"reference-count":321,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Over the past two centuries, vaccines have been critical for the prevention of infectious diseases and are considered milestones in the medical and public health history. The World Health Organization estimates that vaccination currently prevents approximately 3.5\u20135 million deaths annually, attributed to diseases such as diphtheria, tetanus, pertussis, influenza, and measles. Vaccination has been instrumental in eradicating important pathogens, including the smallpox virus and wild poliovirus types 2 and 3. This narrative review offers a detailed journey through the history and advancements in vaccinology, tailored for healthcare workers. It traces pivotal milestones, beginning with the variolation practices in the early 17th century, the development of the first smallpox vaccine, and the continuous evolution and innovation in vaccine development up to the present day. We also briefly review immunological principles underlying vaccination, as well as the main vaccine types, with a special mention of the recently introduced mRNA vaccine technology. Additionally, we discuss the broad benefits of vaccines, including their role in reducing morbidity and mortality, and in fostering socioeconomic development in communities. Finally, we address the issue of vaccine hesitancy and discuss effective strategies to promote vaccine acceptance. Research, collaboration, and the widespread acceptance and use of vaccines are imperative for the continued success of vaccination programs in controlling and ultimately eradicating infectious diseases.<\/jats:p>","DOI":"10.3389\/fpubh.2023.1326154","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T23:43:39Z","timestamp":1704757419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":144,"title":["Two centuries of vaccination: historical and conceptual approach and future perspectives"],"prefix":"10.3389","volume":"11","author":[{"given":"David A.","family":"Montero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto M.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro J.","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A.","family":"Benachi O.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenifer-Yadira","family":"Tovar-Rosero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel A.","family":"O\u00f1ate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"O'Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/313792","article-title":"Epidemiology and unique aspects of aging and infectious diseases","volume":"30","author":"Yoshikawa","year":"2000","journal-title":"Clin Infect Dis."},{"key":"B2","first-page":"621","article-title":"Control of infectious diseases","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.socscimed.2014.02.024","article-title":"Surviving polio in a post-polio world","volume":"107","author":"Groce","year":"2014","journal-title":"Soc Sci Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13023-021-01985-0","article-title":"Osteomyelitis variolosa, an issue inherited from the past: case report and systematic review","volume":"16","author":"Tang","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"092","DOI":"10.4103\/0976-3147.71718","article-title":"Post chicken pox neurological sequelae: three distinct presentations","volume":"1","author":"Paul","year":"2010","journal-title":"J Neurosci Rural Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5744\/bi.2021.0003","article-title":"Beyond mortality","volume":"6","author":"Battles","year":"2021","journal-title":"Bioarchaeol Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.281.1.61","article-title":"Trends in infectious disease mortality in the United States during the 20th century","volume":"281","author":"Armstrong","year":"1999","journal-title":"JAMA."},{"key":"B8","unstructured":"United States life tables, 2017166\n            AriasE\n            XuJ\n          32501200Natl Vital Stat Rep.682019"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1196S","DOI":"10.1093\/ajcn\/55.6.1196S","article-title":"Changes in life expectancy 1900\u20131990","volume":"55","author":"Kinsella","year":"1992","journal-title":"Am J Clin Nutr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(00)04824-8","article-title":"Healthy life expectancy in 191 countries, 1999","volume":"357","author":"Mathers","year":"2001","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/35021206","article-title":"Changing patterns of infectious disease","volume":"406","author":"Cohen","year":"2000","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.15585\/mmwr.mm7034a1","article-title":"Progress toward polio eradication \u2014 worldwide, January 2019\u2013June 2021","volume":"70","author":"Bigouette","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-023-06212-3","article-title":"Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3","volume":"619","author":"Yeh","year":"2023","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S1473-3099(22)00548-5","article-title":"The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era","volume":"22","author":"Franco-Paredes","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.nurpra.2018.12.028","article-title":"The resurgence of measles, mumps, and pertussis","volume":"15","author":"Papachrisanthou","year":"2019","journal-title":"J Nurse Pract."},{"key":"B16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pedn.2018.11.011","article-title":"Is there a resurgence of vaccine preventable diseases in the U.S.?","volume":"44","author":"Kubin","year":"2019","journal-title":"J Pediatr Nurs."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1003418","DOI":"10.1371\/journal.ppat.1003418","article-title":"Pertussis: challenges today and for the future","volume":"9","author":"Cherry","year":"2013","journal-title":"PLoS Pathog."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.590780","article-title":"Major scientific hurdles in HIV vaccine development: historical perspective and future directions","volume":"11","author":"Ng'uni","year":"2020","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/vaccines11091452","article-title":"Malaria vaccines: from the past towards the mRNA vaccine era","volume":"11","author":"Tsoumani","year":"2023","journal-title":"Vaccines."},{"key":"B20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/pathogens12020154","article-title":"Prevention and treatment strategies for respiratory syncytial virus (RSV)","volume":"12","author":"Gatt","year":"2023","journal-title":"Pathogens."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1016\/S2666-5247(23)00195-7","article-title":"First RSV vaccine approvals","volume":"4","author":"Venkatesan","year":"2023","journal-title":"Lancet Microbe."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1080\/21645515.2021.1912551","article-title":"The COVID-19 vaccine social media infodemic : healthcare providers' missed dose in addressing misinformation and vaccine hesitancy","volume":"17","author":"Hernandez","year":"2021","journal-title":"Hum Vaccin Immunother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1550-7408.1975.tb00934.x","article-title":"Three centuries of protozoology: a brief tribute to its founding father, A. van Leeuwenhoek of Delft","volume":"22","author":"Corliss","year":"1975","journal-title":"J Protozool."},{"key":"B24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/188812a0","article-title":"The father of microscopy","volume":"188","author":"Hughes","year":"1960","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1469-0691.2002.00525.x","article-title":"Smallpox\u2014eradicated, but a growing terror threat","volume":"8","author":"Tegnell","year":"2002","journal-title":"Clin Microbiol Infect."},{"key":"B26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-1-4419-1339-5_2","article-title":"\u2018Variolation' and vaccination in late imperial China, Ca 1570\u20131911","volume-title":"History of Vaccine Development","author":"Leung","year":"2011"},{"key":"B27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1034\/j.1600-6143.2003.00145.x","article-title":"Smallpox and live-virus vaccination in transplant recipients","volume":"3","author":"Fishman","year":"2003","journal-title":"Am J Transplant."},{"key":"B28","first-page":"697","volume-title":"Zhangshi Yitong (the Comprehensive Book of Medicine by Zhang Lu)","author":"Lu","year":"1695"},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.20506\/rst.26.1.1724","article-title":"A brief history of vaccines and vaccination","volume":"26","author":"Lombard","year":"2007","journal-title":"Rev Sci Tech."},{"key":"B30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1258\/jrsm.2012.12k044","article-title":"The origins of inoculation","volume":"105","author":"Boylston","year":"2012","journal-title":"J R Soc Med."},{"key":"B31","first-page":"245","article-title":"Early efforts at control: variolation, vaccination, and isolation and quarantine","volume-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"key":"B32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Baylor Univ Med Cent Proc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1016\/j.vaccine.2007.02.076","article-title":"The introduction of variolation \u2018A La Turca' to the West by Lady Mary Montagu and Turkey's contribution to this","volume":"25","author":"Dinc","year":"2007","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1128\/mr.47.4.455-509.1983","article-title":"The smallpox story: life and death of an old disease","volume":"47","author":"Behbehani","year":"1983","journal-title":"Microbiol Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2015.00269","article-title":"Vaccines through centuries: major cornerstones of global health","volume":"3","author":"Hajj Hussein","year":"2015","journal-title":"Front Public Heal."},{"key":"B36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJM192108251850802","article-title":"Experience in Massachusetts and a few other places with smallpox and vaccination","volume":"185","author":"Henry","year":"1921","journal-title":"Bost Med Surg J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/qshc.2007.023465","article-title":"Making the right decision: Benjamin Franklin's son dies of smallpox in 1736","volume":"16","author":"Best","year":"2007","journal-title":"Qual Saf Heal Care."},{"key":"B38","first-page":"44","article-title":"Who discovered smallpox vaccination? Edward Jenner or Benjamin Jesty?","volume":"90","author":"Hammarsten","year":"1979","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/S0140-6736(03)15111-2","article-title":"Benjamin Jesty: new light in the dawn of vaccination","volume":"362","author":"Pead","year":"2003","journal-title":"Lancet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1201-9712(98)90096-0","article-title":"The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered","volume":"3","author":"Gross","year":"1998","journal-title":"Int J Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1016\/j.vaccine.2012.06.059","article-title":"Vaccinology: the name, the concept, the adjectives","volume":"30","author":"Tuells","year":"2012","journal-title":"Vaccine."},{"key":"B42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00010","article-title":"Smallpox: the triumph over the most terrible of the Ministers of Death","volume":"127","author":"Barquet","year":"1997","journal-title":"Ann Intern Med."},{"key":"B43","unstructured":"134\n            JennerE\n          Springfield, MASampson LowAn Inquiry Into the Causes and Effects of the Variolae Vaccinae: A Disease Discovered in Some of the Western Counties of England, Particularly Gloucestershire, Known by the Name of the Cow Pox1798"},{"key":"B44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4419-1339-5_3","article-title":"Edward Jenner's role in the introduction of smallpox vaccine","volume-title":"History of Vaccine Development","author":"Baxby","year":"2011"},{"key":"B45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4419-1339-5_5","article-title":"Smallpox eradication: the vindication of Jenner's Prophesy","volume-title":"History of Vaccine Development","author":"Fenner","year":"2011"},{"key":"B46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1377\/hlthaff.24.3.611","article-title":"The history of vaccines and immunization: familiar patterns, new challenges","volume":"24","author":"Stern","year":"2005","journal-title":"Health Aff."},{"key":"B47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jinf.2005.07.021","article-title":"The history of the smallpox vaccine","volume":"52","author":"Stewart","year":"2006","journal-title":"J Infect."},{"key":"B48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0264-410X(98)00207-2","article-title":"Edward Jenner's Inquiry; a bicentenary analysis","volume":"17","author":"Baxby","year":"1999","journal-title":"Vaccine."},{"key":"B49","first-page":"897","article-title":"La premi\u00e8re vaccination contre la rage","volume":"28","author":"Pasteur","year":"1935","journal-title":"Rev des Deux Mondes."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/clinids\/3.6.1251","article-title":"Who introduced typhoid vaccination: almroth wright or Richard Pfeiffer?","volume":"3","author":"Groschel","year":"1981","journal-title":"Clin Infect Dis."},{"key":"B51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4419-1108-7_6","article-title":"Killed vaccines: cholera, typhoid, and plague","volume-title":"Vaccines: A Biography","author":"Carpenter","year":"2010"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/bmj.1.1902.1461","article-title":"Remarks on the plague prophylactic fluid","volume":"1","author":"Haffkine","year":"1897","journal-title":"BMJ."},{"key":"B53","first-page":"89","article-title":"Pr\u00e9munition des nouveaux-n\u00e9s contre la tuberculose par le vaccin BCG (1921\u20131926)","volume":"2","author":"Calmette","year":"1926"},{"key":"B54","first-page":"1338","article-title":"Sur le pouvoir floculant et sur les proprietes immunisantes d'une toxin diphterique rendu anatoxique (anatosine)","volume":"177","author":"Ramon","year":"1923","journal-title":"CR Acad Sci Paris."},{"key":"B55","first-page":"508","article-title":"Sur l'immunisation antit\u00e9tanique et sur la production de l'antitoxine t\u00e9tanique","volume":"93","author":"Ramon","year":"1925","journal-title":"CR Soc Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2105\/AJPH.26.1.8","article-title":"Progress report on pertussis immunization","volume":"26","author":"Kendrick","year":"1936","journal-title":"Am J Public Health Nations Health."},{"key":"B57","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human. Immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.1955.02960140001001","article-title":"Considerations in the preparation and use of poliomyelitis virus vaccine","volume":"158","author":"Salk","year":"1955","journal-title":"J Am Med Assoc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1001\/jama.1960.03020320001001","article-title":"Live, orally given poliovirus vaccine","volume":"173","author":"Sabin","year":"1960","journal-title":"JAMA."},{"key":"B60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1056\/NEJM196007282630401","article-title":"Studies on an attenuated Measles-virus vaccine","volume":"263","author":"Enders","year":"1960","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJM196802012780501","article-title":"Live, attenuated mumps-virus vaccine","volume":"278","author":"Hilleman","year":"1968","journal-title":"N Engl J Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/archpedi.1969.02100040180004","article-title":"Attenuation of RA 27\/3 Rubella virus in WI-38 human diploid cells","volume":"118","author":"Plotkin","year":"1969","journal-title":"Arch Pediatr Adolesc Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1016\/j.vaccine.2007.07.030","article-title":"Role of US military research programs in the development of US-licensed vaccines for naturally occurring infectious diseases","volume":"25","author":"Kitchen","year":"2007","journal-title":"Vaccine."},{"key":"B65","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev."},{"key":"B66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4899-0369-3_11","volume-title":"The Development of the Hepatitis B Vaccine","author":"Millman","year":"1984"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0140-6736(07)60696-5","article-title":"Robert Austrian","volume":"369","author":"Pincock","year":"2007","journal-title":"Lancet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/jama.276.14.1181","article-title":"Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: impact on public health and implications for other polysaccharide-based vaccines","volume":"276","author":"Robbins","year":"1996","journal-title":"JAMA."},{"key":"B69","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.1093\/infdis\/jiaa537","article-title":"Hib vaccines: their impact on haemophilus influenzae type b disease","volume":"224","author":"Gilsdorf","year":"2021","journal-title":"J Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"S742","DOI":"10.1093\/infdis\/jiab423","article-title":"Modern history of cholera vaccines and the pivotal role of icddr,b","volume":"224","author":"Holmgren","year":"2021","journal-title":"J Infect Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0022-3476(05)80227-6","article-title":"Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children","volume":"120","author":"Podda","year":"1992","journal-title":"J Pediatr."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/21645515.2020.1769389","article-title":"Hepatitis A vaccination","volume":"16","author":"Zhang","year":"2020","journal-title":"Hum Vaccines Immunother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","article-title":"The remarkable history of pneumococcal vaccination: an ongoing challenge","volume":"14","author":"Musher","year":"2022","journal-title":"Pneumonia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/21645515.2015.1011019","article-title":"Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae","volume":"11","author":"O'Ryan","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nbt1207-1377","article-title":"Ian Frazer","volume":"25","author":"Ratner","year":"2007","journal-title":"Nat Biotechnol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00751","article-title":"The development of a vaccine against Meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"Systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2096970","DOI":"10.1080\/21645515.2022.2096970","article-title":"CoronaVac: a review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2","volume":"18","author":"Jin","year":"2022","journal-title":"Hum Vaccin Immunother."},{"key":"B80","doi-asserted-by":"publisher","first-page":"100788","DOI":"10.1016\/j.lanwpc.2023.100788","article-title":"Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis","volume":"37","author":"Law","year":"2023","journal-title":"Lancet Reg Heal West Pacific."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12829","article-title":"Novel viral vectors in infectious diseases","volume":"153","author":"Humphreys","year":"2018","journal-title":"Immunology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/vaccines10030436","article-title":"Utilization of viral vector vaccines in preparing for future pandemics","volume":"10","author":"Hofmeyer","year":"2022","journal-title":"Vaccines."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2200072","article-title":"Randomized trial of vaccines for zaire ebola virus disease","volume":"387","author":"Kieh","year":"2022","journal-title":"N Engl J Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1\u20132a trial of Ad26.COV2.S Covid-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-6632.1999.tb08048.x","article-title":"The cost of disease eradication. Smallpox and bovine tuberculosis","volume":"894","author":"Nelson","year":"1999","journal-title":"Ann N Y Acad Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00068","article-title":"Louis Pasteur, the father of immunology?","volume":"3","author":"Smith","year":"2012","journal-title":"Front Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1469-0691.2012.03945.x","article-title":"Louis Pasteur, from crystals of life to vaccination","volume":"18","author":"Berche","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"B91","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2460\/javma.2000.217.175","article-title":"History, trends, and extent of pasteurization","volume":"217","author":"Steele","year":"2000","journal-title":"J Am Vet Med Assoc."},{"key":"B92","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0140-6736(02)35739-8","volume":"118","year":"1881","journal-title":"Lancet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1017\/S0025727300053813","article-title":"Germ theories of disease and British veterinary medicine, 1860-1890","volume":"35","author":"Worboys","year":"1991","journal-title":"Med Hist."},{"key":"B94","first-page":"175","article-title":"Causation and disease: the Henle-Koch postulates revisited","volume":"49","author":"Evans","year":"1976","journal-title":"Yale J Biol Med."},{"key":"B95","unstructured":"The first live attenuated vaccinesS7\n            BarrancoC\n          Nat Milestones.2842020"},{"key":"B96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/clinids\/3.2.183","article-title":"Pneumococcus: the first one hundred years","volume":"3","author":"Austrian","year":"1981","journal-title":"Clin Infect Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.micinf.2019.06.006","article-title":"Duclaux, Chamberland, Roux, Grancher, and Metchnikoff: the five musketeers of Louis Pasteur","volume":"21","author":"Cavaillon","year":"2019","journal-title":"Microbes Infect."},{"key":"B98","first-page":"429","article-title":"De l'atenuation des virus et de leur retour a la virulence","volume":"92","author":"Pasteur","year":"1881","journal-title":"Compt Rend Acad Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2249.2012.04592.x","article-title":"Developments in rabies vaccines","volume":"169","author":"Hicks","year":"2012","journal-title":"Clin Exp Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/jcp.50.6.454","article-title":"Origins of electron microscopy and viral diagnosis","volume":"50","author":"Madeley","year":"1997","journal-title":"J Clin Pathol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1586\/erv.10.105","article-title":"Experimental rabies vaccines for humans","volume":"9","author":"McGettigan","year":"2010","journal-title":"Expert Rev Vaccines."},{"key":"B103","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrmicro2668","article-title":"The development of vaccines: how the past led to the future","volume":"9","author":"Plotkin","year":"2011","journal-title":"Nat Rev Microbiol."},{"key":"B104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-4419-1339-5_6","article-title":"Pasteur and the birth of vaccines made in the laboratory","volume-title":"History of Vaccine Development","author":"Bazin","year":"2011"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.01048","article-title":"Vaccines against antimicrobial resistance","volume":"11","author":"Rosini","year":"2020","journal-title":"Front Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1576-9887(11)70024-3","article-title":"The process of creating the Pasteur Institute (1886-1888) according to the Spanish press of the time","volume":"12","author":"Tuells","year":"2011","journal-title":"Vacunas."},{"key":"B107","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B108","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization. I. past and present trends","volume":"129","author":"Meyer","year":"1974","journal-title":"J Infect Dis."},{"key":"B109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4419-1339-5_8","article-title":"A history of toxoids","volume-title":"History of Vaccine Development","author":"Relyveld","year":"2011"},{"key":"B110","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1128\/mBio.00117-17","article-title":"Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes","author":"Kaufmann","year":"2017","journal-title":"MBio."},{"key":"B111","unstructured":"DavisonN\n            Neil\n          The Role of Scientific Discovery in the Establishment of the First Biological Weapons Programmes2005"},{"key":"B112","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0163-7258(82)90043-2","article-title":"Diphtheria toxin","volume":"19","author":"Uchida","year":"1982","journal-title":"Pharmacol Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/SMJ.0b013e318224006d","article-title":"Tetanus: a review","volume":"104","author":"Ataro","year":"2011","journal-title":"South Med J."},{"key":"B114","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0264-410X(95)00188-7","article-title":"Three to four instead of one millilitre of formalin","volume":"14","author":"Ebisawa","year":"1996","journal-title":"Vaccine."},{"key":"B115","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/toxins14110759","article-title":"From bacterial poisons to toxins: the early works of Pasteurians","volume":"14","author":"Cavaillon","year":"2022","journal-title":"Toxins"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3201\/eid1608.100288","article-title":"Pearl Kendrick, Grace Eldering, and the pertussis vaccine","volume":"16","author":"Shapiro-Shapin","year":"2010","journal-title":"Emerg Infect Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.vaccine.2019.11.022","article-title":"Pertussis vaccines: The first hundred years","volume":"38","author":"Guiso","year":"2020","journal-title":"Vaccine."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA."},{"key":"B119","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1542\/peds.89.2.318","article-title":"The ricochet of magic bullets: summary of the Institute of Medicine Report, adverse effects of pertussis and rubella vaccines","volume":"89","author":"Howson","year":"1992","journal-title":"Pediatrics."},{"key":"B120","first-page":"E9","article-title":"The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus","volume":"58","author":"Barberis","year":"2017","journal-title":"J Prev Med Hyg."},{"key":"B121","first-page":"29","article-title":"History of tuberculosis. Part 1 - Phthisis, consumption and the White Plague","volume":"22","author":"Frith","year":"2014","journal-title":"J Mil Veterans Heal."},{"key":"B122","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tube.2019.05.003","article-title":"Is cough really necessary for TB transmission?","volume":"117","author":"Patterson","year":"2019","journal-title":"Tuberculosis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"E241","DOI":"10.15167\/2421-4248\/jpmh2018.59.3.1051","article-title":"The never-ending story of the fight against tuberculosis: From Koch's bacillus to global control programs","volume":"59","author":"Martini","year":"2018","journal-title":"J Prev Med Hyg."},{"key":"B124","first-page":"561","article-title":"Contribution \u00e0 l'\u00e9tude du bacille tuberculeux bili\u00e9","volume":"9","author":"Calmette","year":"1921","journal-title":"Ann Inst Pasteur."},{"key":"B125","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2013different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat Rev Microbiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF01644123","article-title":"Bacteremia in connection with transurethral resection of the prostate","volume":"15","author":"Nielsen","year":"1987","journal-title":"Infection."},{"key":"B130","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2016.11.007","article-title":"Tuberculosis eradication versus control","volume":"56","author":"Schito","year":"2017","journal-title":"Int J Infect Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1084\/jem.20072290","article-title":"Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine","volume":"204","author":"Norrby","year":"2007","journal-title":"J Exp Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/(SICI)1099-1654(200001\/02)10:1<3::AID-RMV261>3.0.CO;2-O","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"10","author":"Theiler","year":"2000","journal-title":"Rev Med Virol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/08830185.2015.1082177","article-title":"Anti-infectious human vaccination in historical perspective","volume":"35","author":"D'Amelio","year":"2016","journal-title":"Int Rev Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1586\/14760584.2014.923761","article-title":"Tools and approaches to ensure quality of vaccines throughout the cold chain","volume":"13","author":"Kartoglu","year":"2014","journal-title":"Expert Rev Vaccines."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.1959.03000330001001","article-title":"Poliomyelitis vaccine preparation and administration","volume":"169","author":"Salk","year":"1959","journal-title":"J Am Med Assoc."},{"key":"B136","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4419-1339-5_19","article-title":"Oral polio vaccine and the results of its use","volume-title":"History of Vaccine Development","author":"Melnick","year":"2011"},{"key":"B137","unstructured":"Certification of polio eradication: process and lessons learned2430\n            SmithJ\n            LekeR\n            AdamsA\n            TangermannRH\n          15106297Bull World Health Organ.822004"},{"key":"B138","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/QCO.0000000000000667","article-title":"Final frontiers of the polio eradication endgame","volume":"33","author":"Bandyopadhyay","year":"2020","journal-title":"Curr Opin Infect Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e2190","DOI":"10.1002\/rmv.2190","article-title":"Impact of COVID-19 on polio vaccination in Pakistan: a concise overview","volume":"31","author":"Din","year":"2021","journal-title":"Rev Med Virol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nrmicro1550","article-title":"Global measles elimination","volume":"4","author":"Moss","year":"2006","journal-title":"Nat Rev Microbiol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet."},{"key":"B142","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/archpedi.1969.02100040174003","article-title":"Experimental live attenuated rubella virus vaccine","volume":"118","author":"Prinzie","year":"1969","journal-title":"Am J Dis Child."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(73)93375-8","article-title":"Letter: Rubella vaccination","volume":"2","author":"Thomson","year":"1973","journal-title":"Lancet."},{"key":"B144","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/archpedi.1962.02080020347030","article-title":"Development of attenuated Measles virus vaccines","volume":"103","author":"Enders","year":"1962","journal-title":"Am J Dis Child."},{"key":"B145","first-page":"590","article-title":"John F. Enders and measles virus vaccine\u2014a reminiscence","volume-title":"Measles. History and Basic Biology. Current Topics in Microbiology and Immunology.","author":"Katz","year":"2009"},{"key":"B146","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJM196609152751101","article-title":"Attenuated rubella virus","volume":"275","author":"Parkman","year":"1966","journal-title":"N Engl J Med."},{"key":"B147","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-7069(06)15004-1","article-title":"Chapter 4: Rubella Vaccine","volume-title":"Rubella Viruses. Perspectives in Medical Virology.","author":"Reef","year":"2006"},{"key":"B148","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1093\/clinids\/7.Supplement_1.S73","article-title":"Licensed vaccines","volume":"7","author":"Perkins","year":"1985","journal-title":"Clin Infect Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7883\/yoken.JJID.2015.162","article-title":"Persistence of immunity acquired after a single dose of rubella vaccine in Japan","volume":"69","author":"Okafuji","year":"2016","journal-title":"Jpn J Infect Dis."},{"key":"B150","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.1971.03190140033006","article-title":"Trivalent combined measles-mumps-rubella vaccine","volume":"218","author":"Stokes","year":"1971","journal-title":"JAMA."},{"key":"B151","doi-asserted-by":"publisher","first-page":"o818","DOI":"10.1136\/bmj.o818","article-title":"We need to increase MMR vaccine uptake urgently","volume":"376","author":"Bedford","year":"2022","journal-title":"BMJ."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.3928\/00904481-20150410-08","article-title":"Vaccine-preventable outbreaks: still with us after all these years","volume":"44","author":"Ruderfer","year":"2015","journal-title":"Pediatr Ann."},{"key":"B153","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.idc.2021.11.010","article-title":"Updates in the epidemiology, approaches to vaccine coverage and current outbreaks of measles","volume":"36","author":"Peart Akindele","year":"2022","journal-title":"Infect Dis Clin North Am."},{"key":"B154","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0196-4399(85)80097-0","article-title":"Live attenuated varicella vaccine","volume":"7","author":"Gershon","year":"1985","journal-title":"Clin Microbiol Newsl."},{"key":"B155","first-page":"85","article-title":"Cancer prevention by vaccination against hepatitis B","volume-title":"Cancer Prevention II","author":"Chang","year":"2011"},{"key":"B156","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1073\/pnas.94.14.7121","article-title":"Hepatitis B virus, the vaccine, and the control of primary cancer of the liver","volume":"94","author":"Blumberg","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B157","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","article-title":"A review of vaccine research and development: meningococcal disease","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine."},{"key":"B158","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0035-9203(91)90338-Y","article-title":"Meningococcal molecular mimicry and the search for an ideal vaccine","volume":"85","author":"Griffiss","year":"1991","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B159","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0022-3476(85)80502-3","article-title":"Haemophilus influenzae type b polysaccharide vaccines","volume":"107","author":"Granoff","year":"1985","journal-title":"J Pediatr."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02388078","article-title":"Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides","volume":"58","author":"van Dam","year":"1990","journal-title":"Antonie Van Leeuwenhoek."},{"key":"B161","doi-asserted-by":"publisher","first-page":"S598","DOI":"10.1093\/clinids\/11.Supplement_3.S598","article-title":"Pneumococcal polysaccharide vaccines","volume":"11","author":"Austrian","year":"1989","journal-title":"Clin Infect Dis."},{"key":"B162","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0022-3476(85)80504-7","article-title":"Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b","volume":"107","author":"Anderson","year":"1985","journal-title":"J Pediatr."},{"key":"B163","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1098\/rstb.2012.0147","article-title":"The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?","volume":"368","author":"Maiden","year":"2013","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","article-title":"Conjugate vaccines","volume":"119","author":"Goldblatt","year":"2002","journal-title":"Clin Exp Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0264-410X(99)00276-5","article-title":"Safety and immunogenicity of a new Neisseria meningitidis serogroup C- tetanus toxoid conjugate vaccine in healthy adults","volume":"18","author":"Richmond","year":"1999","journal-title":"Vaccine."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/j.vaccine.2018.02.107","article-title":"Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children","volume":"36","author":"Hansen","year":"2018","journal-title":"Vaccine."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1155751","DOI":"10.3389\/fmed.2023.1155751","article-title":"Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development","volume":"10","author":"Montero","year":"2023","journal-title":"Front Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/0264-410X(92)90557-Z","article-title":"Production quality control and charaterization of an inactivated hepatitis A vaccine","volume":"10","author":"Peetermans","year":"1992","journal-title":"Vaccine."},{"key":"B169","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/01.inf.0000220283.58039.b6","article-title":"The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants","volume":"25","author":"Clark","year":"2006","journal-title":"Pediatr Infect Dis J."},{"key":"B170","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.1016\/S2214-109X(20)30262-X","article-title":"Real-world effectiveness of rotavirus vaccines, 2006\u201319: a literature review and meta-analysis","volume":"8","author":"Burnett","year":"2020","journal-title":"Lancet Glob Heal."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1080\/21645515.2016.1168952","article-title":"Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States","volume":"12","author":"Gee","year":"2016","journal-title":"Hum Vaccines Immunother."},{"key":"B172","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","article-title":"Human papillomavirus vaccine against cervical cancer: opportunity and challenge","volume":"471","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"key":"B173","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/B978-0-12-802302-0.00002-9","article-title":"Reverse vaccinology: exploiting genomes for vaccine design","author":"Del Tordello","year":"2017","journal-title":"Human Vaccines. Emerging Technologies in Design and Development."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B177","doi-asserted-by":"publisher","first-page":"646","DOI":"10.4161\/hv.7.6.15482","article-title":"The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans","volume":"7","author":"Toneatto","year":"2011","journal-title":"Hum Vaccin."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1080\/21645515.2018.1458175","article-title":"Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines","volume":"14","author":"Villena","year":"2018","journal-title":"Hum Vaccin Immunother."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S1473-3099(23)00191-3","article-title":"Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial","volume":"23","author":"Peterson","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"B180","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.addr.2021.01.014","article-title":"SARS-CoV-2 vaccines in advanced clinical trials: where do we stand?","volume":"172","author":"Chakraborty","year":"2021","journal-title":"Adv Drug Deliv Rev."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.abn1755","article-title":"COVID-19 vaccination: the road ahead","volume":"1132","author":"Altmann","year":"2022","journal-title":"Science."},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-023-00996-2","article-title":"The role of vaccines in the COVID-19 pandemic: what have we learned?","author":"Krammer","year":"2023","journal-title":"Semin Immunopathol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"14999","DOI":"10.1073\/pnas.0802555105","article-title":"Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells","volume":"105","author":"Gonz\u00e1lez","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3389\/fimmu.2020.01507","article-title":"Current insights in the development of efficacious vaccines against RSV","volume":"11","author":"Soto","year":"2020","journal-title":"Front Immunol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"34108","DOI":"10.1038\/srep34108","article-title":"Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus","volume":"6","author":"Killikelly","year":"2016","journal-title":"Sci Rep."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/EBC20160017","article-title":"The immune system","volume":"60","author":"Nicholson","year":"2016","journal-title":"Essays Biochem."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2215\/CJN.04680514","article-title":"How the innate immune system senses trouble and causes trouble","volume":"10","author":"Hato","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2215\/CJN.09430915","article-title":"B cells, antibodies, and more","volume":"11","author":"Hoffman","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02692","article-title":"Defining memory CD8 T cell","volume":"9","author":"Martin","year":"2018","journal-title":"Front Immunol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jconrel.2016.05.033","article-title":"Orchestrating immune responses: how size, shape and rigidity affect the immunogenicity of particulate vaccines","volume":"234","author":"Benne","year":"2016","journal-title":"J Control Release."},{"key":"B195","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.272.5258.54","article-title":"Immunological memory and protective immunity: understanding their relation","volume":"272","author":"Ahmed","year":"1996","journal-title":"Science."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cti.2016.81","article-title":"Vaccination to gain humoral immune memory","volume":"5","author":"Sarkander","year":"2016","journal-title":"Clin Transl Immunol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol."},{"key":"B199","first-page":"165","article-title":"Vaccine development: from preclinical studies to phase 1\/2 clinical trials","volume-title":"Malaria Control and Elimination. Methods in Molecular Biology, Vol. 2013.","author":"Artaud","year":"2019"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12961-020-00571-3","article-title":"From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?","volume":"18","author":"Hanney","year":"2020","journal-title":"Heal Res Policy Syst."},{"key":"B201","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40290-021-00397-6","article-title":"The emergency use authorization of pharmaceuticals: history and utility during the COVID-19 pandemic","volume":"35","author":"Tran","year":"2021","journal-title":"Pharmaceut Med."},{"key":"B202","doi-asserted-by":"publisher","first-page":"20132839","DOI":"10.1098\/rspb.2013.2839","article-title":"Veterinary and human vaccine evaluation methods","volume":"281","author":"Knight-Jones","year":"2014","journal-title":"Proc R Soc B Biol Sci."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aat0360","article-title":"Design of vaccine efficacy trials during public health emergencies","volume":"11","author":"Dean","year":"2019","journal-title":"Sci Transl Med."},{"key":"B204","doi-asserted-by":"publisher","first-page":"e00084","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B205","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"80","author":"Minor","year":"2015","journal-title":"Virology."},{"key":"B206","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4161\/hv.5.5.7559","article-title":"Towards development of stable formulations of a live attenuated bacterial vaccine: a preformulation study facilitated by a biophysical approach","volume":"5","author":"Zeng","year":"2009","journal-title":"Hum Vaccin."},{"key":"B207","doi-asserted-by":"publisher","first-page":"C14","DOI":"10.1016\/j.vaccine.2010.07.020","article-title":"Principles of vaccine design\u2014Lessons from nature","volume":"28","author":"Zepp","year":"2010","journal-title":"Vaccine."},{"key":"B208","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.addr.2014.10.002","article-title":"Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges","volume":"93","author":"Tlaxca","year":"2015","journal-title":"Adv Drug Deliv Rev."},{"key":"B209","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S0264-410X(98)00046-2","article-title":"Inactivated whole-cell bacterial vaccines: current status and novel strategies","volume":"16","author":"Pace","year":"1998","journal-title":"Vaccine."},{"key":"B211","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1586\/erv.12.38","article-title":"Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges","volume":"11","author":"Delrue","year":"2012","journal-title":"Expert Rev Vaccines."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jobb.2020.12.001","article-title":"Heat inactivation of the severe acute respiratory syndrome coronavirus 2","volume":"3","author":"Bat\u00e9jat","year":"2021","journal-title":"J Biosaf Biosecurity."},{"key":"B213","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1016\/j.vaccine.2014.09.052","article-title":"Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines","volume":"32","author":"Keller-Stanislawski","year":"2014","journal-title":"Vaccine."},{"key":"B214","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imm.13526","article-title":"Vaccines, adjuvants and key factors for mucosal immune response","volume":"167","author":"Correa","year":"2022","journal-title":"Immunology."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/vaccines10071120","article-title":"Advances in infectious disease vaccine adjuvants","volume":"10","author":"Fan","year":"2022","journal-title":"Vaccines."},{"key":"B216","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/293479a0","article-title":"Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK","volume":"293","author":"King","year":"1981","journal-title":"Nature."},{"key":"B217","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrmicro979","article-title":"From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza","volume":"2","author":"Wood","year":"2004","journal-title":"Nat Rev Microbiol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem."},{"key":"B219","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000525468","article-title":"Whole-cell and acellular pertussis vaccine: reflections on efficacy","volume":"31","author":"Alghounaim","year":"2022","journal-title":"Med Princ Pract."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bmb\/ldh021","article-title":"Bacterial polysaccharide\u2013protein conjugate vaccines","volume":"70","author":"Finn","year":"2004","journal-title":"Br Med Bull."},{"key":"B221","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/BA20000034","article-title":"Design and production of recombinant subunit vaccines","volume":"32","author":"Hansson","year":"2000","journal-title":"Biotechnol Appl Biochem."},{"key":"B222","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0264-410X(97)00288-0","article-title":"Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids*1","volume":"16","author":"Relyveld","year":"1998","journal-title":"Vaccine."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0140-6736(96)05243-9","article-title":"A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned","volume":"348","author":"Schneerson","year":"1996","journal-title":"Lancet."},{"key":"B225","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","article-title":"The value of childhood combination vaccines: from beliefs to evidence","volume":"11","author":"Maman","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B226","doi-asserted-by":"publisher","first-page":"771","DOI":"10.4067\/S0370-41062017000600771","article-title":"Episodio Hipoton\u00eda-Hiporreactividad posterior a la inmunizaci\u00f3n con vacuna combinada con pertussis de c\u00e9lulas enteras","volume":"88","author":"Velasco","year":"2017","journal-title":"Rev Chil Pediatr."},{"key":"B227","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14740338.2022.2007882","article-title":"Safety evaluation of the DTaP5-IPV-Hib-HepB vaccine: a review","volume":"21","author":"Fortunato","year":"2022","journal-title":"Expert Opin Drug Saf."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/microorganisms10071450","article-title":"Viral vector vaccine development and application during the COVID-19 pandemic","volume":"10","author":"Deng","year":"2022","journal-title":"Microorganisms."},{"key":"B229","doi-asserted-by":"publisher","first-page":"100432","DOI":"10.1016\/j.dmpk.2021.100432","article-title":"Adenovirus vector-based vaccine for infectious diseases","volume":"42","author":"Sakurai","year":"2022","journal-title":"Drug Metab Pharmacokinet."},{"key":"B230","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/infdis\/jiaa409","article-title":"Safety and immunogenicity of the Ad26.RSV.preF investigational vaccine coadministered with an influenza vaccine in older adults","volume":"223","author":"Sadoff","year":"2021","journal-title":"J Infect Dis."},{"key":"B231","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/infdis\/jiad108","article-title":"Reduced load, symptoms, and infections: a human challenge respiratory syncytial virus trial of MVA-BN-RSV vaccine","volume":"228","author":"Jordan","year":"2023","journal-title":"J Infect Dis"},{"key":"B232","doi-asserted-by":"publisher","first-page":"100766","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today."},{"key":"B233","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/imr.13089","article-title":"Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines","volume":"310","author":"Sette","year":"2022","journal-title":"Immunol Rev."},{"key":"B234","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/cei.13517","article-title":"Vaccines for COVID-19","volume":"202","author":"Tregoning","year":"2020","journal-title":"Clin Exp Immunol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1517\/17425247.2014.901308","article-title":"Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines","volume":"11","author":"Deering","year":"2014","journal-title":"Expert Opin Drug Deliv."},{"key":"B236","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/vaccines10040591","article-title":"The importance of vaccination in the context of the COVID-19 pandemic: a brief update regarding the use of vaccines","volume":"10","author":"Machado","year":"2022","journal-title":"Vaccines."},{"key":"B237","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/08971900211009650","article-title":"Review of COVID-19 mRNA vaccines: BNT162b2 and mRNA-1273","volume":"35","author":"Teo","year":"2022","journal-title":"J Pharm Pract."},{"key":"B238","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA vaccines in the COVID-19 pandemic and beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu Rev Med."},{"key":"B239","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/d41586-023-00220-z","article-title":"The next generation of coronavirus vaccines: a graphical guide","volume":"614","author":"Callaway","year":"2023","journal-title":"Nature."},{"key":"B240","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1473-3099(23)00122-6","article-title":"Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study","volume":"23","author":"Arbel","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"B241","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi","year":"2021","journal-title":"Mol Ther."},{"key":"B243","doi-asserted-by":"publisher","first-page":"103897","DOI":"10.1016\/j.amsu.2022.103897","article-title":"Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19","volume":"78","author":"Poudel","year":"2022","journal-title":"Ann Med Surg."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1078197","DOI":"10.3389\/fimmu.2023.1078197","article-title":"Guillain-Barre syndrome following COVID-19 vaccines: a review of literature","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"196","DOI":"10.20944\/preprints202208.0151.v1","article-title":"Cardiovascular manifestation of the BNT162b2 mRNA COVID-19 vaccine in adolescents","volume":"7","author":"Mansanguan","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"B246","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.bioactmat.2022.11.014","article-title":"Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics","volume":"23","author":"Yang","year":"2023","journal-title":"Bioact Mater."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3389\/fmicb.2020.01526","article-title":"Impact of vaccines; health, economic and social perspectives","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Front Microbiol"},{"key":"B248","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine."},{"key":"B249","doi-asserted-by":"publisher","first-page":"eadf1093","DOI":"10.1126\/scitranslmed.adf1093","article-title":"Vaccines for a sustainable planet","volume":"15","author":"Pecetta","year":"2023","journal-title":"Sci Transl Med"},{"key":"B250","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3201\/eid2711.203372","article-title":"Toward cholera elimination, Haiti","volume":"27","author":"Rebaudet","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"B251","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMsr1904253","article-title":"The ongoing ebola epidemic in the Democratic Republic of Congo, 2018\u20132019","volume":"381","author":"Ilunga Kalenga","year":"2019","journal-title":"N Engl J Med."},{"key":"B252","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/vaccines11020224","article-title":"A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by the omicron variant (B11529)","volume":"11","author":"Mohammed","year":"2023","journal-title":"Vaccines."},{"key":"B253","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(22)00087-3","article-title":"The overlooked pandemic of antimicrobial resistance","volume":"399","author":"Laxminarayan","year":"2022","journal-title":"Lancet."},{"key":"B254","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet."},{"key":"B255","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1086\/430954","article-title":"Influenza virus neuraminidase contributes to secondary bacterial pneumonia","volume":"192","author":"Peltola","year":"2005","journal-title":"J Infect Dis."},{"key":"B256","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/INF.0b013e3181a487b4","article-title":"Efficacy of injectable trivalent virosomal-adjuvanted inactivated influenza vaccine in preventing acute otitis media in children with recurrent complicated or noncomplicated acute otitis media","volume":"28","author":"Marchisio","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"B257","doi-asserted-by":"publisher","first-page":"CD010089","DOI":"10.1002\/14651858.CD010089.pub3","article-title":"Influenza vaccines for preventing acute otitis media in infants and children","volume":"2017","author":"Norhayati","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B258","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina","year":"2015","journal-title":"Science."},{"key":"B259","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(10)62352-5","article-title":"Measles","volume":"379","author":"Moss","year":"2012","journal-title":"Lancet."},{"key":"B260","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aay6485","article-title":"Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens","volume":"366","author":"Mina","year":"2019","journal-title":"Science."},{"key":"B261","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/ije\/dyg005","article-title":"The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh","volume":"32","author":"Aaby","year":"2003","journal-title":"Int J Epidemiol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1023\/A:1007626510002","article-title":"Herd immunity and herd effect: new insights and definitions","volume":"16","author":"John","year":"2000","journal-title":"Eur J Epidemiol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.immuni.2020.04.012","article-title":"Herd Immunity: understanding COVID-19","volume":"52","author":"Randolph","year":"2020","journal-title":"Immunity."},{"key":"B264","doi-asserted-by":"publisher","first-page":"e000613","DOI":"10.1136\/bmjgh-2017-000613","article-title":"Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study","volume":"3","author":"Riumallo-Herl","year":"2018","journal-title":"BMJ Glob Heal."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1539\/joh.48.1","article-title":"Workplace vaccination against Influenza in Malaysia: does the employer benefit?","volume":"48","author":"Samad","year":"2006","journal-title":"J Occup Health."},{"key":"B266","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","article-title":"Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review","volume":"31","author":"Ozawa","year":"2012","journal-title":"Vaccine."},{"key":"B267","doi-asserted-by":"publisher","first-page":"26962","DOI":"10.3402\/jmahp.v3.26962","article-title":"The societal role of lifelong vaccination","volume":"3","author":"Postma","year":"2015","journal-title":"J Mark Access Heal Policy."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1080\/21645515.2019.1708669","article-title":"Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination","volume":"16","author":"Nandi","year":"2020","journal-title":"Hum Vaccin Immunother."},{"key":"B269","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/hec.732","article-title":"Measles vaccination improves the equity of health outcomes: evidence from Bangladesh","volume":"12","author":"Bishaia","year":"2003","journal-title":"Health Econ."},{"key":"B270","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/icb.2009.15","article-title":"Vaccines, global health and social equity","volume":"87","author":"Levine","year":"2009","journal-title":"Immunol Cell Biol."},{"key":"B271","doi-asserted-by":"publisher","first-page":"103140","DOI":"10.1016\/j.pce.2022.103140","article-title":"COVID-19 vaccine-induced recovery and the implications of vaccine apartheid on the global tourism industry","volume":"126","author":"Dube","year":"2022","journal-title":"Phys Chem Earth, Parts A\/B\/C."},{"key":"B272","unstructured":"63Report of the SAGEWorking Group on Vaccine Hesitancy2014"},{"key":"B273","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine."},{"key":"B274","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.4161\/hv.24888","article-title":"Addressing heterogeneous parental concerns about vaccination with a multiple-source model: a parent and educator perspective","volume":"9","author":"Hagood","year":"2013","journal-title":"Hum Vaccines Immunother."},{"key":"B275","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1586\/14760584.2015.964212","article-title":"Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications","volume":"14","author":"Dub\u00e9","year":"2015","journal-title":"Expert Rev Vaccines."},{"key":"B276","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-68106-1_2","article-title":"A brief history of anti-vaccination movements","volume-title":"Vaccines: Are they Worth a Shot?","author":"Grignolio","year":"2018"},{"key":"B277","doi-asserted-by":"publisher","first-page":"e2919","DOI":"10.7759\/cureus.2919","article-title":"The anti-vaccination movement: a regression in modern medicine","volume":"10","author":"Hussain","year":"2018","journal-title":"Cureus."},{"key":"B278","first-page":"22","article-title":"The impact on public health of the 19th century anti-vaccination movement","volume":"30","author":"Howard","year":"2003","journal-title":"Microbiol Today."},{"key":"B279","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cppeds.2010.01.003","article-title":"Controversies in vaccine mandates","volume":"40","author":"Lantos","year":"2010","journal-title":"Curr Probl Pediatr Adolesc Health Care."},{"key":"B280","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s40506-020-00219-4","article-title":"The growing threat of vaccine resistance: a global crisis","volume":"12","author":"Zaidi","year":"2020","journal-title":"Curr Treat Options Infect Dis."},{"key":"B281","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/003335490712200215","article-title":"Immunity for the people: the challenge of achieving high vaccine coverage in American history","volume":"122","author":"Colgrove","year":"2007","journal-title":"Public Health Rep."},{"key":"B282","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00006454-198704000-00005","article-title":"Pertussis in Sweden after the cessation of general immunization in 1979","volume":"6","author":"Romanus","year":"1987","journal-title":"Pediatr Infect Dis J."},{"key":"B283","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/clinids\/14.3.708","article-title":"Epidemiological Features of Pertussis in the United States, 1980\u20131989","volume":"14","author":"Farizo","year":"1992","journal-title":"Clin Infect Dis."},{"key":"B284","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/315535","article-title":"Diphtheria in the Russian Federation in the 1990s","volume":"181","author":"Markina","year":"2000","journal-title":"J Infect Dis"},{"key":"B285","doi-asserted-by":"publisher","first-page":"12236","DOI":"10.1073\/pnas.1516574112","article-title":"Vaccines and autism in primate model","volume":"112","author":"Offit","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B286","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1086\/596476","article-title":"Vaccines and autism: a tale of shifting hypotheses","volume":"48","author":"Gerber","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B287","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-virology-092818-015515","article-title":"The MMR vaccine and autism","volume":"6","author":"DeStefano","year":"2019","journal-title":"Annu Rev Virol."},{"key":"B288","first-page":"49","volume-title":"Vaccine Additives and Excipients","author":"Domachowske","year":"2021"},{"key":"B289","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1542\/peds.107.5.1147","article-title":"An assessment of thimerosal use in childhood vaccines","volume":"107","author":"Ball","year":"2001","journal-title":"Pediatrics."},{"key":"B290","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1056\/NEJMoa071434","article-title":"Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years","volume":"357","author":"Thompson","year":"2007","journal-title":"N Engl J Med."},{"key":"B291","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-4614-7438-8_11","article-title":"Thimerosal and other vaccine additives","volume-title":"Vaccinophobia and Vaccine Controversies of the 21st Century","author":"Conway","year":"2013"},{"key":"B292","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2007.113159","article-title":"Mercury, Vaccines, and Autism","volume":"98","author":"Baker","year":"2008","journal-title":"Am J Public Health."},{"key":"B293","doi-asserted-by":"publisher","first-page":"e2023301118","DOI":"10.1073\/pnas.2023301118","article-title":"The echo chamber effect on social media","volume":"118","author":"Cinelli","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"B294","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1080\/21645515.2020.1780846","article-title":"Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases","volume":"16","author":"Puri","year":"2020","journal-title":"Hum Vaccines Immunother."},{"key":"B295","doi-asserted-by":"publisher","first-page":"2013694","DOI":"10.1080\/21645515.2021.2013694","article-title":"The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic","volume":"18","author":"Ouyang","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"B296","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.puhe.2021.02.025","article-title":"Vaccine hesitancy in the era of COVID-19","volume":"194","author":"Troiano","year":"2021","journal-title":"Public Health."},{"key":"B297","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2020.01.001","article-title":"Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles","volume":"41","author":"Hotez","year":"2020","journal-title":"Curr Opin Virol."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamapediatrics.2013.2353","article-title":"Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age","volume":"167","author":"Glanz","year":"2013","journal-title":"JAMA Pediatr."},{"key":"B299","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jlme.12305","article-title":"Funding the costs of disease outbreaks caused by non-vaccination","volume":"43","author":"Moser","year":"2015","journal-title":"J Law Med Ethics."},{"key":"B300","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/jamapediatrics.2013.2483","article-title":"The relationship between parent attitudes about childhood vaccines survey scores and future child immunization status: a validation study","volume":"167","author":"Opel","year":"2013","journal-title":"JAMA Pediatr."},{"key":"B301","unstructured":"Understanding the behavioural and social drivers of vaccine uptake: WHO position paper \u2013 May 202220924Wkly Epidemiol Rec972022"},{"key":"B302","doi-asserted-by":"publisher","first-page":"100140","DOI":"10.1016\/j.jvacx.2021.100140","article-title":"Explaining the intention to uptake COVID-19 vaccination using the behavioral and social drivers of vaccination (BeSD) model","volume":"10","author":"Alagarsamy","year":"2022","journal-title":"Vaccine X."},{"key":"B303","doi-asserted-by":"publisher","first-page":"e2024597118","DOI":"10.1073\/pnas.2024597118","article-title":"Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust","volume":"118","author":"Petersen","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"B304","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1097\/INF.0000000000003499","article-title":"Effective approaches to combat vaccine hesitancy","volume":"41","author":"Tuckerman","year":"2022","journal-title":"Pediatr Infect Dis J."},{"key":"B305","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1080\/21645515.2020.1735226","article-title":"How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation","volume":"16","author":"Jacobson","year":"2020","journal-title":"Hum Vaccin Immunother."},{"key":"B306","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.puhe.2019.09.007","article-title":"Supporting informed decision-making about vaccination: an analysis of two official websites","volume":"178","author":"Vivion","year":"2020","journal-title":"Public Health."},{"key":"B307","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0253644","article-title":"Comparing the impact of an icon array versus a bar graph on preference and understanding of risk information: Results from an online, randomized study","volume":"16","author":"Scalia","year":"2021","journal-title":"PLoS ONE."},{"key":"B308","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines10111893","article-title":"Vaccine champions training program: empowering community leaders to advocate for COVID-19 vaccines","volume":"10","author":"Kaufman","year":"2022","journal-title":"Vaccines."},{"key":"B309","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/17579139221145616","article-title":"Enhancing the training of community engagement officers to address vaccine hesitancy: a university and local authority collaboration","volume":"143","author":"Murdan","year":"2023","journal-title":"Perspect Public Health."},{"key":"B310","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/10810730.2021.1873463","article-title":"Community-based strategies to engage pastors can help address vaccine hesitancy and health disparities in black communities","volume":"25","author":"Privor-Dumm","year":"2020","journal-title":"J Health Commun."},{"key":"B311","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1177\/1524839917697303","article-title":"The immunity community: a community engagement strategy for reducing vaccine hesitancy","volume":"18","author":"Schoeppe","year":"2017","journal-title":"Health Promot Pract."},{"key":"B312","doi-asserted-by":"publisher","first-page":"e27632","DOI":"10.2196\/27632","article-title":"Assessing COVID-19 vaccine hesitancy, confidence, and public engagement: a global social listening study","volume":"23","author":"Hou","year":"2021","journal-title":"J Med Internet Res."},{"key":"B313","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(14)60196-3","article-title":"Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial","volume":"384","author":"Weaver","year":"2014","journal-title":"Lancet."},{"key":"B314","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/d41586-019-02232-0","article-title":"Mandate vaccination with care","volume":"571","author":"Omer","year":"2019","journal-title":"Nature."},{"key":"B315","doi-asserted-by":"publisher","first-page":"106763","DOI":"10.1016\/j.ypmed.2021.106763","article-title":"Issues surrounding incentives and penalties for COVID-19 vaccination: the Israeli experience","volume":"153","author":"Saban","year":"2021","journal-title":"Prev Med (Baltim)."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41590-019-0488-9","article-title":"Vaccine hesitancy and coercion: all eyes on France","volume":"20","author":"Ward","year":"2019","journal-title":"Nat Immunol."},{"key":"B317","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/14760584.2022.2011226","article-title":"Will the mRNA vaccine platform be the panacea for the development of vaccines against antimicrobial resistant (AMR) pathogens?","volume":"21","author":"Chen","year":"2022","journal-title":"Expert Rev Vaccines."},{"key":"B318","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/d41573-022-00035-z","article-title":"The mRNA vaccine development landscape for infectious diseases","volume":"21","author":"Kumar","year":"2022","journal-title":"Nat Rev Drug Discov."},{"key":"B319","doi-asserted-by":"publisher","first-page":"e1898","DOI":"10.1371\/journal.pone.0001898","article-title":"Host genetic factors and vaccine-induced immunity to hepatitis B virus infection","volume":"3","author":"Hennig","year":"2008","journal-title":"PLoS ONE."},{"key":"B320","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/jmv.27485","article-title":"Host factors and vaccine efficacy: implications for COVID-19 vaccines","volume":"94","author":"Falahi","year":"2022","journal-title":"J Med Virol."},{"key":"B321","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41541-022-00443-7","article-title":"Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine","volume":"7","author":"Moon","year":"2022","journal-title":"npj Vaccines."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1326154\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T23:44:03Z","timestamp":1704757443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1326154\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":321,"alternative-id":["10.3389\/fpubh.2023.1326154"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1326154","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"article-number":"1326154"}}